Biochemical markers of liver fibrosis in HCV patients

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Evaluation of endoglin as a non–invasive marker of hepatic fibrosis in chronic hepatitis C patients

A study of non-invasive method for liver fibrosis and prediction of hepatocellular carcinoma

Clinical biochemical and histological profile of chronic hepatitis c patients with normal serum aminotransferases

3 Biochemical markers in blood can predict cirrhotic evolution of chronic hepatitis

Morphometric ultrastrutural study of nucleus and intercellular spaces in patients with chronic hepatitis C virus infection and hepatocellular carcinoma

Serum levels of neopterinin patients with hepatitis C virus relatedchronic liver disease

Serum hepcidin levels in chronic hepatitis C patients

significance of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma